tirzepatide tablets fda approved accepts generic bids as new pill outperforms Ozempic πNew GLP-1 pill gets FDA
Description
Retatrutide: investigational Retatrutide has no FDA approval
Diabetes Care, 46 (5), 9981004
Across all of these, the pattern is the same
Comparison reflects published facility status and standard industry practice
The treatment also increased the likelihood of achieving substantial weight loss milestones, with more Tirzepatide users losing 10% or more of their body weight
